New histone tag discovery offers hope for myelin repair in neurodegenerative diseases

In a groundbreaking study, researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have identified a distinct histone tag in adult oligodendrocyte progenitor cells (OPCs) that may pave the way for innovative therapies targeting myelin repair, a critical target for several neurodegenerative and psychiatric disorders, including multiple sclerosis, Alzheimer’s disease, and schizophrenia.

Kyowa Kirin acquires ex-US rights to Kura’s leukemia treatment for $330M upfront

Japanese drugmaker Kyowa Kirin is acquiring most of the commercial rights for Kura Oncology’s targeted leukemia treatment, paying $330 million upfront and almost $1.2 billion

November 22, 2024

Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins

Medtronic announced FDA approval of its first disposable, all-in-one continuous glucose monitor (CGM) Simplera, which is half the size of the maker’s previous devices. Over

August 14, 2024

Scientists take a (small) step toward universal antivenom

Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s case, the recipe is straightforward: Pump a horse full of

February 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.